172 related articles for article (PubMed ID: 478635)
1. Flagella-induced immunity against experimental cholera in adult rabbits.
Yancey RJ; Willis DL; Berry LJ
Infect Immun; 1979 Jul; 25(1):220-8. PubMed ID: 478635
[TBL] [Abstract][Full Text] [Related]
2. Improved protection against cholera in adult rabbits with a combined flagellar-toxoid vaccine.
Resnick IG; Ford CW; Shackleford GM; Berry LJ
Infect Immun; 1980 Nov; 30(2):375-80. PubMed ID: 7439983
[TBL] [Abstract][Full Text] [Related]
3. Synergistic protection against experimental cholera by immunization with cholera toxoid and vaccine.
Peterson JW
Infect Immun; 1979 Nov; 26(2):528-33. PubMed ID: 546785
[TBL] [Abstract][Full Text] [Related]
4. Motility of the pathogen and intestinal immunity of the host in experimental cholera.
Yancey RJ; Berry LJ
Adv Exp Med Biol; 1978; 107():447-55. PubMed ID: 742500
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of surface components of Vibrio cholerae as protective immunogens.
Eubanks ER; Guentzel MN; Berry LJ
Infect Immun; 1977 Feb; 15(2):533-8. PubMed ID: 844905
[TBL] [Abstract][Full Text] [Related]
6. Immunity in experimental cholera: effect of parenteral immunization with vaccines and toxoid.
Sinha VB; Bhaskaran K
Bull World Health Organ; 1973; 49(6):605-13. PubMed ID: 4548387
[TBL] [Abstract][Full Text] [Related]
7. Role of motility in experimental cholera in adult rabbits.
Yancey RJ; Willis DL; Berry LJ
Infect Immun; 1978 Nov; 22(2):387-92. PubMed ID: 730361
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of a bivalent (CVD 103-HgR/CVD 111) live oral cholera vaccine in adult volunteers from the United States and Peru.
Taylor DN; Tacket CO; Losonsky G; Castro O; Gutierrez J; Meza R; Nataro JP; Kaper JB; Wasserman SS; Edelman R; Levine MM; Cryz SJ
Infect Immun; 1997 Sep; 65(9):3852-6. PubMed ID: 9284163
[TBL] [Abstract][Full Text] [Related]
9. [Experimental research on cholera vaccines. Local immunity].
Manakhilov RB; Genova IuG; Bogatinov VT; Kostova EF
Zh Mikrobiol Epidemiol Immunobiol; 1986 Oct; (10):59-62. PubMed ID: 3799104
[TBL] [Abstract][Full Text] [Related]
10. [Systemic immunity of experimental animals immunized with cholera vaccines].
Genova IuG; Bogatinov VT; Manakhilov RB; Kostova EF
Zh Mikrobiol Epidemiol Immunobiol; 1987 Nov; (11):41-4. PubMed ID: 3434048
[TBL] [Abstract][Full Text] [Related]
11. Antitoxic immunity in experimental cholera: protection, and serum and local antibody responses in rabbits after enteral and parenteral immunization.
Holmgren J; Svennerholm AM; Ouchterlony O; Anderson A; Walletström G; Westerberg-Berndtsson U
Infect Immun; 1975 Dec; 12(6):1331-40. PubMed ID: 54337
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity and protective capacity of inactivated "vibrio cholerae" whole cell vaccines.
Cryz SJ; Fürer E; Germanier R
Dev Biol Stand; 1983; 53():67-72. PubMed ID: 6873478
[TBL] [Abstract][Full Text] [Related]
13. Protection in rabbits induced by the Texas Star-SR attenuated A-B+ mutant candidate live oral cholera vaccine.
Boesman-Finkelstein M; Finkelstein RA
Infect Immun; 1982 Apr; 36(1):221-6. PubMed ID: 7076295
[TBL] [Abstract][Full Text] [Related]
14. Protection of suckling mice from experimental cholera by maternal immunization: comparison of the efficacy of whole-cell, ribosomal-derived, and enterotoxin immunogens.
Guentzel MN; Berry LJ
Infect Immun; 1974 Jul; 10(1):167-72. PubMed ID: 4601899
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and protective role of three formulations of oral cholera vaccine.
Kalambaheti T; Chaisri U; Srimanote P; Pongponratn E; Chaicumpa W
Vaccine; 1998; 16(2-3):201-7. PubMed ID: 9607031
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the protective efficacy of Vibrio cholerae ghost (VCG) candidate vaccines in rabbits.
Eko FO; Schukovskaya T; Lotzmanova EY; Firstova VV; Emalyanova NV; Klueva SN; Kravtzov AL; Livanova LF; Kutyrev VV; Igietseme JU; Lubitz W
Vaccine; 2003 Sep; 21(25-26):3663-74. PubMed ID: 12922096
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to the truncated (short) form of 'O' polysaccharides (TFOP) of Vibrio cholerae O139 lipopolysaccharides protect mice against experimental cholera induced by encapsulated O139 strains and such protection is mediated by inhibition of intestinal colonization of vibrios.
Nandy RK; Mukhopadhyay S; Ghosh AN; Ghose AC
Vaccine; 1999 Jul; 17(22):2844-52. PubMed ID: 10438055
[TBL] [Abstract][Full Text] [Related]
18. Intranasal immunization with recombinant toxin-coregulated pilus and cholera toxin B subunit protects rabbits against Vibrio cholerae O1 challenge.
Kundu J; Mazumder R; Srivastava R; Srivastava BS
FEMS Immunol Med Microbiol; 2009 Jul; 56(2):179-84. PubMed ID: 19453752
[TBL] [Abstract][Full Text] [Related]
19. Construction and evaluation of a safe, live, oral Vibrio cholerae vaccine candidate, IEM108.
Liang W; Wang S; Yu F; Zhang L; Qi G; Liu Y; Gao S; Kan B
Infect Immun; 2003 Oct; 71(10):5498-504. PubMed ID: 14500467
[TBL] [Abstract][Full Text] [Related]
20. Construction of a recombinant live oral vaccine from a non-toxigenic strain of Vibrio cholerae O1 serotype inaba biotype E1 Tor and assessment of its reactogenicity and immunogenicity in the rabbit model.
Thungapathra M; Sharma C; Gupta N; Ghosh RK; Mukhopadhyay A; Koley H; Nair GB; Ghosh A
Immunol Lett; 1999 Jun; 68(2-3):219-27. PubMed ID: 10424424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
